Skip to contentS
Strata Critical Medical, Inc.
S
SRTAStrata Critical Medical, Inc. Q2 2025 · 10-Q
Revenue$45.11M$45.11M−33.6% vs Q2 2024 Net Income-$3.74M-$3.74MN/M vs Q2 2024 EPS Diluted-$0.05-$0.05N/M vs Q2 2024 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Strata Critical Medical, Inc. · CIK 1779128 · Engraved from SEC EDGAR
Operating Cash Flowderived-$3,064,000N/M Free Cash Flowderived-$5,299,000N/M Margins · derivedGross margin20.0%
Operating margin-10.3%+7.6 pt vs Q2 2024
Net margin-8.3%+8.4 pt vs Q2 2024
ended Jun 30, 2025 · filed Aug 5, 2025 · 36 d after period end